Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – A substantial proportion of women with cervical cancer who receive curative-intent radiotherapy will soon develop pelvic fractures, clinicians from the University of Texas…
EW YORK (Reuters Health) – Low-risk patients with ST-segment elevation myocardial infarction (STEMI) treated with angioplasty can be discharged within 72 hours, Canadian investigators suggest. Although STEMI patients…
NEW YORK (Reuters Health) – A new feeding tube that’s inserted while attached to an ultra-thin gastroscope will avoid the potentially disastrous consequences of blind tube placement, researchers…
Kevin Hauser, Director New Business Development at MedeFile International discusses the advanced features and benefits of their technology. These include MedeMinder and the Interactive Healthcare Calendar, which function…
Kevin Hauser, Director of New Business Development at MedeFile International discusses their technology. MedeFile has developed a proprietary system for gathering and digitizing medical records so that individuals…
NEW YORK (Reuters Health) – The nucleoside reverse transcriptase inhibitors (NRTIs) abacavir and didanosine, and the protease inhibitors (PIs) indinavir and lopinavir-ritonavir, all increase the risk of myocardial…
NEW YORK (Reuters Health) – Daily treatment with diazoxide prompts a decrease in HbA1c in patients with newly diagnosed type 1 diabetes, Norwegian researchers report in the December…
David Heber, MD, Professor of Medicine, Director, UCLA Center for Human Nutrition, discusses dietary supplements, the guidelines for which are changing, and now include recommendations for a daily…
Joshua Grill, PhD, Director, Katherine and Benjamin Kagan Alzheimer’s Disease Treatment Development Program, UCLA, discusses biomarkers in Alzheimer’s Disease, which are currently used in clinical trials as inclusion…
Yan Trokel, MD, Cosmetic Surgeon, Founder and Director The YAN Center for Corrective & Cosmetic Surgery, discusses body contouring using the “Zerona” device, a procedure not recommended for…
